These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3520204)

  • 1. Cianidanol therapy for HBe-antigen-positive chronic hepatitis: a multicentre, double-blind study.
    Suzuki H; Yamamoto S; Hirayama C; Takino T; Fujisawa K; Oda T
    Liver; 1986 Feb; 6(1):35-44. PubMed ID: 3520204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B.
    Lee SD; Tong MJ; Wu JC; Lin HC; Tsai YT; Lo KJ
    J Hepatol; 1991 Mar; 12(2):246-50. PubMed ID: 2051004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
    Fattovich G; Rugge M; Brollo L; Pontisso P; Noventa F; Guido M; Alberti A; Realdi G
    Hepatology; 1986; 6(2):167-72. PubMed ID: 3957228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBeAg/anti-HBe seroconversion during and after protracted immunosuppressive treatment in type B chronic hepatitis.
    Tanno H; Fay OH; Rojman JA; Palazzi J; Bessone F
    J Med Virol; 1988 May; 25(1):45-51. PubMed ID: 3045258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathophysiological aspects of chronic active hepatitis.
    Iwamura K
    Tokai J Exp Clin Med; 1986; 11 Suppl():147-57. PubMed ID: 3452239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
    Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
    Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe.
    Sagnelli E; Piccinino F; Manzillo G; Felaco FM; Filippini P; Maio G; Pasquale G; Izzo CM
    Hepatology; 1983; 3(5):690-5. PubMed ID: 6618436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of extract from human tubercle bacilli (SSM) on HBeAg positive type B chronic hepatitis].
    Fujisaki S; Satomura K; Aramaki T; Okumura H
    Nihon Ika Daigaku Zasshi; 1991 Apr; 58(2):165-72. PubMed ID: 2066388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP; Lepiorz H; Berthold H; Gerok W
    Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group.
    Krogsgaard K; Marcellin P; Trepo C; Berthelot P; Sanchez-Tapias JM; Bassendine M; Tran A; Ouzan D; Ring-Larsen H; Lindberg J; Enriquez J; Benhamou JP; Bindslev N
    J Hepatol; 1996 Dec; 25(6):803-13. PubMed ID: 9007706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.
    Bar-Meir S; Halpern Z; Gutman M; Shpirer Z; Baratz M; Bass D
    Gut; 1985 Sep; 26(9):975-9. PubMed ID: 3896964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postpartum subsidence of hepatitis B viral replication in HBeAg-positive carrier mothers.
    Lin HH; Chen PJ; Chen DS; Sung JL; Yang KH; Young YC; Liou YS; Chen YP; Lee TY
    J Med Virol; 1989 Sep; 29(1):1-6. PubMed ID: 2584955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic HBeAg-positive hepatitis with acyclovir. A controlled trial.
    Guarascio P; De Felici AP; Migliorini D; Alexander GJ; Fagan EA; Visco G
    J Hepatol; 1986; 3 Suppl 2():S143-7. PubMed ID: 3298405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
    Tsutsumi Y; Kakumu S; Wakita T; Yoshioka K; Ishikawa T
    J Immunol; 1990 Mar; 144(6):2389-93. PubMed ID: 2313098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
    Chlumská A; Stránský J; Taimr P; Baumruk L; Nevaril M
    Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.